Engineering Strategies to Modulate the Gut Microbiome and Immune System
The Journal of Immunology · 15.01.2024 · 212 (2) · 208-215
DOI: 10.4049/jimmunol.2300480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 15.01.2024. Verfasst von Kai Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota, Probiotics, Autoimmune Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
The gut microbiota, predominantly residing in the colon, is a complex ecosystem with a pivotal role in the host immune system. Dysbiosis of the gut microbiota has been associated with various diseases, and there is an urgent need to develop new therapeutics that target the microbiome and restore immune functions. This Brief Review discusses emerging therapeutic strategies that focus on oral delivery systems for modulating the gut microbiome. These strategies include genetic engineering of probiotics, probiotic-biomaterial hybrids, dietary fibers, and oral delivery systems for microbial metabolites, antimicrobial peptides, RNA, and antibiotics. Engineered oral formulations have demonstrated promising outcomes in reshaping the gut microbiome and influencing immune responses in preclinical studies. By leveraging these approaches, the interplay between the gut microbiota and the immune system can be harnessed for the development of novel therapeutics against cancer, autoimmune disorders, and allergies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI.
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
- Biointerfaces Institute, University of Michigan, Ann Arbor, MI.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI.
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI.
ORCID-Profile: Kai Han, Julia Crowther, James J Moon
Förderung
- NINDS NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIBIB NIH HHS
- NIDCR NIH HHS
- NCI NIH HHS
- HHS | NIH | National Cancer Institute
Zitieren
APA
Han, K., Xu, J., Xie, F., Crowther, J., & Moon, J. J. (2024). Engineering Strategies to Modulate the Gut Microbiome and Immune System. The Journal of Immunology, 212(2), 208-215. https://doi.org/10.4049/jimmunol.2300480
Vancouver
Han K, Xu J, Xie F, Crowther J, Moon JJ. Engineering Strategies to Modulate the Gut Microbiome and Immune System. The Journal of Immunology. 2024;212(2):208-215. doi:10.4049/jimmunol.2300480
BibTeX
@article{Han2024,
author = {Han, Kai and Xu, Jin and Xie, Fang and Crowther, Julia and Moon, James J},
title = {Engineering Strategies to Modulate the Gut Microbiome and Immune System},
journal = {The Journal of Immunology},
year = {2024},
volume = {212},
number = {2},
pages = {208--215},
doi = {10.4049/jimmunol.2300480}
}
EUVIMED